Is molecular imaging the best way to determine response to treatment?
Suzanne Louis Topalian
The importance of specialist nurses in the Radium-223 service for prostate cancer patients
ECCO 2017: treatment value vs affordability
Testing novel biomarkers for treatment
Overview of Helsinn-sponsored symposium focused on chemotherapy and irritable bowel syndrome